KTN's online platform helps you to make the connections you need

 

The Knowledge Transfer Network (KTN) has refreshed its online platform to intelligently connect you to relevant events, funding, thought pieces and specialist staff to help your business innovate and grow.

You can discover content using your area of interest, from Defence Security to transport; from space to health – all major UK economic sectors are covered. Once you have selected your interests, using our intelligent tagging system, we will then display rich and relevant content related to your area, often from surprising sources.

An example might be new satellite technology from the space sector that is applicable in the agri-food sector. KTN-UK.co.uk will help you form these unusual and valuable connections.

All content on the platform has been carefully curated by our team of innovation specialists – not by an automated algorithm – so you can be confident that KTN is connecting you to the most relevant cutting-edge information.

 

The move also marks a closer alignment with our main funder, Innovate UK , with the website branding making a clear visual link. Knowledge Transfer Network is Innovate UK's innovation network partner, and also works with other funders to provide innovation networking services and fulfil our mission to drive UK growth.

We link new ideas and opportunities with expertise, markets and finance through our network of businesses, universities, funders and investors. From agri-food to autonomous systems and from energy to design, KTN combines expertise in all sectors with the ability to cross boundaries. Connecting with KTN can lead to potential partners, horizon-expanding events and innovation insights relevant to your needs.

Visit our people pages to connect directly with expertise in your sector.

Visit the KTN refreshed online platfom here

Entries with tag cancer .

UK Biobank launches world's largest imaging project to shed new light on major diseases

The world’s largest health imaging study, funded by the MRC, Wellcome Trust, and the British Heart Foundationopens in new window (BHF) is launched today. It will create the biggest collection of scans of internal organs, and transform the way scientists study a wide range of diseases, including dementia, arthritis, cancer, heart attacks and strokes. To read the article in full,...
Read More About UK Biobank launches world's largest imaging project to shed new light on major diseases »

MedImmune and Regeneron Enter into Licensing Agreement for the Development of Antibody Drug Conjugates to Treat Cancer

MedImmune, the global biologics research and development arm of AstraZeneca and Regeneron Pharmaceuticals, Inc., today announced that they have entered into a licensing agreement under which Regeneron will use MedImmune’s pyrrolobenzodiazepine (PBD)-based warhead and linker technology to produce antibody-drug conjugates (ADCs) as potential cancer treatments. Regeneron will have exclusive...
Read More About MedImmune and Regeneron Enter into Licensing Agreement for the Development of Antibody Drug Conjugates to Treat Cancer »

Research & Innovation Showcase Focusing on Diagnostics & therapeutics for cancer, inflammation and musculoskeletal disease

Venue: Liverpool Medical Institution, Liverpool, L3 5SR Date: 26 May 2016 Free event - We look forward to welcoming you to Liverpool. Focusing on Diagnostics & therapeutics for cancer, inflammation and musculoskeletal disease this one-day conference aims to facilitate engagement between industry and the University of Liverpool. Hear...
Read More About Research & Innovation Showcase Focusing on Diagnostics & therapeutics for cancer, inflammation and musculoskeletal disease »

Sensors for Cancer Diagnosis

Sensors for Cancer Diagnosis 22 - 23 June 2016 Boston Marriott Cambridge Cambridge MA, USA This new conference will bring together academic researchers, clinicians and the medical device industry to explore the current and future opportunities for the application of biosensors and other sensor technology in the diagnosis of cancer. The Conference will include: Invited...
Read More About Sensors for Cancer Diagnosis »

Economic Evaluation for Oncology

This training day focusses on the development of economic models specifically in the area of oncology. The sessions will include overviews of the most common methods for modelling treatments for cancer, and will pay particular attention to the areas that prove most challenging in HTA, including survival curve analysis, data extrapolation, quality of life modelling (including adverse events),...
Read More About Economic Evaluation for Oncology »

Biotherapeutics device attracts $7m investment

A Cambridge life sciences company that has developed a revolutionary system for single-cell analysis in the biopharmaceutical market, with support from Innovate UK, has secured private investment totalling $7 million. Sphere Fluidics  Ltd’s Cyto-Mine® device promises to transform the discovery and development of biotherapeutics for treatment of cancer and inflammatory diseases and...
Read More About Biotherapeutics device attracts $7m investment »

Cancer Research UK - Pioneer Award

The Pioneer Award offers £200,000 to encourage innovative ideas from  any  discipline that could be groundbreaking in tackling cancer. The Award backs higher risk, truly novel ideas that have the potential for high reward in understanding, preventing, diagnosing or treating cancer. Funding for your idea up to £200,000 over two years Judged by a diverse committee of...
Read More About Cancer Research UK - Pioneer Award »

Nano World Cancer Day 2016

Nano World Cancer Day, 2 nd Februrary 2016 UK Venue: Seminar Room 4, University of Liverpool in London, 33 Finsbury Square, London, EC2A 1AG. The Nano World Cancer Day Nanomedicine is applied nanotechnology to achieve innovation in healthcare. It virtually impacts all therapeutic areas, including oncology, cardiovascular diseases and neurologic disorders. With...
Read More About Nano World Cancer Day 2016 »

Could your expertise and knowledge help save lives?

Cancer Research UK’s Cancer Prevention Innovation Workshop.  The workshop is a unique approach to funding population research - over three days, participants will explore cancer challenges, build new collaborations, think innovatively and develop a pitch for new innovative research ideas that are potentially funded on the spot. Successful teams are awarded seed-funding to...
Read More About Could your expertise and knowledge help save lives? »

Innovation: over 500 UK patients gain early access to new skin cancer treatment

MSD successfully put their advanced new melanoma treatment through MHRA's early access to medicine scheme (EAMS). Speeding up patient access to new, promising, innovative treatments is a current priority for the UK government, regulatory agencies and the pharmaceutical industry. MHRA ’s early access to medicines scheme ( EAMS ) aims to offer patients with life-threatening or...
Read More About Innovation: over 500 UK patients gain early access to new skin cancer treatment »

Meet the cancer fighting Apple Watch app - the future of digital health is now

We're well versed in the concept of patients of the future uploading symptoms for doctors to manage in real time. What we didn't know until now is that this future has arrived. King's College Hospital in London is piloting a scheme in which cancer patients going through chemotherapy treatments are given an Apple Watch running Medopad's  Apple Watch  Chemotherapy app. ...
Read More About Meet the cancer fighting Apple Watch app - the future of digital health is now »

Funding to catalyse a revolution in how we prevent, diagnose, and treat cancer

Grand Challenge awards are the most ambitious cancer research grants in the world. They’re intended to catalyse a revolution in how we prevent, diagnose, and treat cancer by bringing together the brightest minds around the globe, providing the freedom to undertake innovative, game-changing research. Cancer Research UK are looking for applications from...
Read More About Funding to catalyse a revolution in how we prevent, diagnose, and treat cancer »

Cancer Research UK – Grand Challenge

Grand Challenge is a series of £20 million funding awards which look to accelerate progress using a collaborative, interdisciplinary and multinational approach to tackle some of the toughest challenges in cancer. For further information, please click here .
Read More About Cancer Research UK – Grand Challenge »

Cancer Research UK and MedImmune launch ground-breaking biotherapeutics research centre in Cambridge

The new laboratory that will focus on the discovery and development of novel biologic cancer treatments and diagnostics has been opened in Cambridge by life sciences minister George Freeman MP. The state-of-the-art CRUK-MEDI Alliance Laboratory, located on Granta Park, is an innovative collaboration between Cancer Research UK, its commercial arm Cancer Research Technology, and MedImmune,...
Read More About Cancer Research UK and MedImmune launch ground-breaking biotherapeutics research centre in Cambridge »

MedImmune and 3M Collaborate on TLR Agonist Cancer Therapies

MedImmune, the global biologics research and development arm of AstraZeneca, and 3M Drug Delivery Systems, today announced a research collaboration focused on developing next generation toll-like receptor (TLR) agonists - promising agents that activate innate immune cells and enhance the visibility of cancer tumors. Further information here
Read More About MedImmune and 3M Collaborate on TLR Agonist Cancer Therapies »

English cancer survival rates continue to increase.

The Office for National Statistics have, released new data for cancer survival rates in England. The release ‘Cancer Survival rates in England for Adults Diagnosed, 2008 to 2012, followed up to 2013.’ highlights the trend of increasing survival continued for cancer patients diagnosed during 2008–2012. Figures from the report also highlight: Survival is generally lower for older...
Read More About English cancer survival rates continue to increase. »

Google developing disease detecting wristbands.

Google is aiming to diagnose cancers, impending heart attacks or strokes and other diseases, at a much earlier stage than is currently possible, report the BBC. The company is working on technology that combines disease-detecting nanoparticles, which would enter a patient's bloodstream via a swallowed pill, with a wrist-worn sensor. The idea is to identify slight changes in the...
Read More About Google developing disease detecting wristbands. »
Showing 17 results.
Items per Page 25
of 1